In glioma, we investigated that LAIR‐1 overexpression was interrelated with clinicopathologic features such as grade, IDH status, 1p/19q non‐co‐deletion, and MGMT, suggesting that LAIR‐1 overexpression participates a role in the malignant behavior of glioma. Here, LAIR1 is linked to central nervous system cancer.